|
1
|
Peres LC, Cushing-Haugen KL, Köbel M,
Harris HR, Berchuck A, Rossing MA, Schildkraut JM and Doherty JA:
Invasive epithelial ovarian cancer survival by histotype and
disease stage. J Natl Cancer Inst. 111:60–68. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cannistra SA: Cancer of the ovary. N Engl
J Med. 351:2519–2529. 2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Buergy D, Wenz F, Groden C and Brockmann
MA: Tumor-platelet interaction in solid tumors. Int J Cancer.
130:2747–2760. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Nishijima TF, Muss HB, Shachar SS, Tamura
K and Takamatsu Y: Prognostic value of lymphocyte-to-monocyte ratio
in patients with solid tumors: A systematic review and
meta-analysis. Cancer Treat Rev. 41:971–978. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shrotriya S, Walsh D, Bennani-Baiti N,
Thomas S and Lorton C: C-reactive protein is an important biomarker
for prognosis tumor recurrence and treatment response in adult
solid tumors: A systematic review. PLoS One.
10(e0143080)2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Templeton AJ, Ace O, McNamara MG,
Al-Mubarak M, Vera-Badillo FE, Hermanns T, Seruga B, Ocaña A,
Tannock IF and Amir E: Prognostic role of platelet to lymphocyte
ratio in solid tumors: A systematic review and meta-analysis.
Cancer Epidemiol Biomarkers Prev. 23:1204–1212. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Templeton AJ, McNamara MG, Šeruga B,
Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G,
Knox JJ, Tran B, et al: Prognostic role of neutrophil-to-lymphocyte
ratio in solid tumors: A systematic review and meta-analysis. J
Natl Cancer Inst. 106(dju124)2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Orditura M, Galizia G, Diana A, Saccone C,
Cobellis L, Ventriglia J, Iovino F, Romano C, Morgillo F, Mosca L,
et al: Neutrophil to lymphocyte ratio (NLR) for prediction of
distant metastasis-free survival (DMFS) in early breast cancer: A
propensity score-matched analysis. ESMO Open.
1(e000038)2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wei B, Yao M, Xing C, Wang W, Yao J, Hong
Y, Liu Y and Fu P: The neutrophil lymphocyte ratio is associated
with breast cancer prognosis: An updated systematic review and
meta-analysis. Onco Targets Ther. 9:5567–5575. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tang L, Li X, Wang B, Luo G, Gu L, Chen L,
Liu K, Gao Y and Zhang X: Prognostic Value of
neutrophil-to-lymphocyte ratio in localized and advanced prostate
cancer: A systematic review and meta-analysis. PLoS One.
11(e0153981)2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Xue P, Kanai M, Mori Y, Nishimura T, Uza
N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S and
Chiba T: Neutrophil-to-lymphocyte ratio for predicting palliative
chemotherapy outcomes in advanced pancreatic cancer patients.
Cancer Med. 3:406–415. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Cho IR, Park JC, Park CH, Jo JH, Lee HJ,
Kim S, Shim CN, Lee H, Shin SK, Lee SK and Lee YC: Pre-treatment
neutrophil to lymphocyte ratio as a prognostic marker to predict
chemotherapeutic response and survival outcomes in metastatic
advanced gastric cancer. Gastric Cancer. 17:703–710.
2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Nakamura K, Nagasaka T, Nishida T, Haruma
T, Ogawa C, Kusumoto T, Seki N and Hiramatsu Y: Neutrophil to
lymphocyte ratio in the pre-treatment phase of final-line
chemotherapy predicts the outcome of patients with recurrent
ovarian cancer. Oncol Lett. 11:3975–3981. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Menon S, Shin S and Dy G: Advances in
cancer immunotherapy in solid tumors. Cancers (Basel).
8(106)2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kusumanto YH, Dam WA, Hospers GA, Meijer C
and Mulder NH: Platelets and granulocytes, in particular the
neutrophils, form important compartments for circulating vascular
endothelial growth factor. Angiogenesis. 6:283–287. 2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hagerling C, Casbon AJ and Werb Z:
Balancing the innate immune system in tumor development. Trends
Cell Biol. 25:214–220. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Murray PJ, Allen JE, Biswas SK, Fisher EA,
Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence
T, et al: Macrophage activation and polarization: Nomenclature and
experimental guidelines. Immunity. 41:14–20. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Pillay J, Tak T, Kamp VM and Koenderman L:
Immune suppression by neutrophils and granulocytic myeloid-derived
suppressor cells: Similarities and differences. Cell Mol Life Sci.
70:3813–3827. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Walker JA, Barlow JL and McKenzie AN:
Innate lymphoid cells-how did we miss them? Nat Rev Immunol.
13:75–87. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lin EY and Pollard JW: Role of infiltrated
leucocytes in tumour growth and spread. Br J Cancer. 90:2053–2058.
2004.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Güngör N, Knaapen AM, Munnia A, Peluso M,
Haenen GR, Chiu RK, Godschalk RW and van Schooten FJ: Genotoxic
effects of neutrophils and hypochlorous acid. Mutagenesis.
25:149–154. 2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Nicolás-Ávila J, Adrover JM and Hidalgo A:
Neutrophils in homeostasis, immunity, and cancer. Immunity.
46:15–28. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Uribe-Querol E and Rosales C: Neutrophils
in cancer: Two sides of the same coin. J Immunol Res.
2015(983698)2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899.
2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Raungkaewmanee S, Tangjitgamol S,
Manusirivithaya S, Srijaipracharoen S and Thavaramara T: Platelet
to lymphocyte ratio as a prognostic factor for epithelial ovarian
cancer. J Gynecol Oncol. 23:265–273. 2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Liu R, Zheng S, Yuan Q, Zhu P, Li B, Lin
Q, Shi W, Min Y, Ge Q and Shao Y: The prognostic significance of
combined pretreatment fibrinogen and neutrophil-lymphocyte ratio in
various cancers: A systematic review and meta-analysis. Dis
Markers. 2020(4565379)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Peng SM, Yu N, Ren JJ, Xu JY, Chen GC,
Yang JR, Li ZN, Du HZ, Li DP, Zhang YS and Qin LQ: The Geriatric
Nutritional Risk Index as a prognostic factor in patients with
advanced non-small-cell lung cancer. Nutr Cancer: Dec 24, 2020
(Epub ahead of print). doi: 10.1080/01635581.2020.1865423.
|
|
32
|
Luo X, Yu B, Jiang N, Du Q, Ye X, Li H,
Wang WQ and Zhai Q: Chemotherapy-induced reduction of
neutrophil-to-lymphocyte ratio is associated with better survival
in pancreatic adenocarcinoma: A meta-analysis. Cancer Control.
27(1073274820977135)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Nogueira-Costa G, Fernandes I, Gameiro R,
Gramaça J, Xavier AT and Pina I: Prognostic utility of
neutrophil-to-lymphocyte ratio in patients with metastatic
colorectal cancer treated using different modalities. Curr Oncol.
27:237–243. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Iwai N, Okuda T, Sakagami J, Harada T,
Ohara T, Taniguchi M, Sakai H, Oka K, Hara T, Tsuji T, et al:
Neutrophil to lymphocyte ratio predicts prognosis in unresectable
pancreatic cancer. Sci Rep. 10(18758)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Vernieri C, Mennitto A, Prisciandaro M,
Huber V, Milano M, Rinaldi L, Cona MS, Maggi C, Ferrari B,
Manoukian S, et al: The neutrophil-to-lymphocyte and
platelet-to-lymphocyte ratios predict efficacy of platinum-based
chemotherapy in patients with metastatic triple negative breast
cancer. Sci Rep. 8(8703)2018.PubMed/NCBI View Article : Google Scholar
|
